Global (DES) Drug-Eluting Stent Market 2014-2018

Global Drug-eluting Stent (DES) Market 2014-2018 a new industry research report available at


Dallas, TX -- (SBWIRE) -- 02/05/2014 -- Increasing demand for minimally-invasive procedures has been witnessed among members of the rapidly aging population across the world, and this is expected to boost the growth of the Global Drug-eluting Stent market. In addition, the cost efficiencies offered by less invasive methods are likely to increase the demand for the procedures in the near future. Minimally-invasive endovascular procedures are surgeries performed through minute incisions in the body. Such procedures can be used to treat plaque blockages in the arteries of the heart and other vessel walls of peripheral organs such as the kidneys and the brain. The principal advantages of these procedures over conventional surgeries are the short recovery time, the short length of the scars resulting in less physical trauma, low risk of infection, and minimized bleeding, and the shorter hospital stays associated with these surgeries.

Analysts forecast the Global Drug-eluting Stent (DES) market to grow at a CAGR of 5.79 percent over the period 2013-2018. According to the report, one of the key drivers is the increase in the number of patients suffering from CVD. An unhealthy diet and lack of physical activity are the major factors leading to the increase in the number of people prone to CVD.

Purchase a report @

The Global Drug-eluting Stent (DES) Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Drug Eluting Stent market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Further, the report states that the biggest challenge the market is facing is the decline in the ASP of DESs. There has been a steady decline in the prices of DESs worldwide because of the increased competition and the high rate of adoption. The reduction in the ASP has a negative impact on the overall market revenue.

The report recognizes the following companies as the key players in Global Drug-eluting Stent Market: Abbott Laboratories, Boston Scientific Corp., Medtronic Inc., and Terumo Corp.

Other vendors mentioned in the report are B. Braun Melsungen AG, Biosensors International Ltd., BIOTRONIK SE & Co. KG, Cook Medical Inc., Lepu Medical Technology Co. Ltd., MicroPort Scientific Corp., and Sorin Group USA Inc.

Key questions answered in this report:
- What will the market size be in 2018 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Table Of Contents
01. Executive Summary

02. List of Abbreviations

03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05. Introduction

06. Market Landscape
06.1 Market Overview
06.2 Global Coronary Stents Market
06.2.1 Market Size and Forecast
06.2.2 Market Segmentation
06.3 Global DES Market
06.3.1 Market Size and Forecast
06.3.2 Market Size in Volume
06.3.3 ASP of DES
06.4 DES Market in China
06.5 DES Market in Europe
06.6 Five Forces Analysis

07. Market Segmentation by Types of Drugs
07.1 Global DES Market by Types of Drugs
07.1.1 Drugs Used in DES as Anti-neoplastics
07.1.2 Drugs Used in DES as Immunosupressives
07.1.3 Drugs Used in DES as Migration Inhibitors
07.1.4 Drugs Used in DES as Enhanced Healing Factors
07.2 Top-selling Drugs used in DES
07.3 Top-selling DES

08. Geographical Segmentation
08.1 Global DES Market by Geographical Segmentation

09. Key Leading Countries
09.1 US
09.2 China
09.3 Germany
09.4 Japan

10. Rate of Incidence and Prevalence

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Market Share Analysis 2013
18.3 Other Prominent Vendors

19. Key Vendor Analysis
19.1 Abbott Laboratories
19.1.1 Business Overview
19.1.2 Business Segmentation
19.1.3 Key Information
19.1.4 SWOT Analysis
19.2 Boston Scientific Corp.
19.2.1 Business Overview
19.2.2 Business Segmentation
19.2.3 Key Information
19.2.4 SWOT Analysis
19.3 Medtronic Inc.
19.3.1 Business Overview
19.3.2 Business Segmentation
19.3.3 Key Information
19.3.4 SWOT Analysis
19.4 Terumo Corp.
19.4.1 Business Overview
19.4.2 Business Segmentation
19.4.3 Key Information
19.4.4 SWOT Analysis

20. Other Reports in this Series

List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Coronary Stent Market Segmentation
Exhibit 3: Global Coronary Stents Market 2013-2018 (US$ billion)
Exhibit 4: Global Coronary Stents Market Segmentation by Stent Type (in percentage)
Exhibit 5: Global DES Market 2013-2018 (US$ billion)
Exhibit 6: Global DES Market 2013-2018 (units in thousands)
Exhibit 7: Average Selling Price of Drug-eluting Stents 2013-2018 (US$)
Exhibit 8: DES Market in China 2013-2018 (US$ million)
Exhibit 9: DES Market in Europe 2013-2018 (US$ billion)
Exhibit 10: Global DES Market Segmentation by Types of Drugs
Exhibit 11: Global DES Market by Geographical Segmentation 2013
Exhibit 12: Global DES Market by Vendor Segmentation 2013
Exhibit 13: Business Segmentation of Abbott Laboratories
Exhibit 14: Business Segmentation of Boston Scientific Corp.
Exhibit 15: Business Segmentation of Medtronic Inc.
Exhibit 16: Business Segmentation of Terumo Corp.